celecoxib has been researched along with Fifth Phacomatosis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We then assessed the effects of celecoxib on the development of BCCs in a 3-year, double-blinded, randomized clinical trial in 60 (PTCH1(+/-)) patients with the basal cell nevus syndrome." | 5.14 | Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice. ( Aszterbaum, M; Athar, M; Barsanti, F; Bickers, DR; Cappola, C; Epstein, EH; Estevez, N; Hebert, J; Hwang, J; Khaimskiy, Y; Kim, A; Kohn, MA; Kopelovich, L; Lu, Y; McCulloch, CE; So, PL; Tang, JY; Tang, X, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, JY | 1 |
| Aszterbaum, M | 1 |
| Athar, M | 1 |
| Barsanti, F | 1 |
| Cappola, C | 1 |
| Estevez, N | 1 |
| Hebert, J | 1 |
| Hwang, J | 1 |
| Khaimskiy, Y | 1 |
| Kim, A | 1 |
| Lu, Y | 1 |
| So, PL | 1 |
| Tang, X | 1 |
| Kohn, MA | 1 |
| McCulloch, CE | 1 |
| Kopelovich, L | 1 |
| Bickers, DR | 1 |
| Epstein, EH | 1 |
1 trial available for celecoxib and Fifth Phacomatosis
| Article | Year |
|---|---|
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; | 2010 |